Filing Flows › ProPhase Labs (PRPH) › Q4 2025
ProPhase Labs (PRPH) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Jun 1, 2026
ProPhase Labs (PRPH) reported revenue of $784K for the fourth quarter 2025 (Q4 2025), -48% from a year earlier and -11% from the quarter before. Operating margin was -730.4%, net loss $7.4M (943.6% of revenue).
ProPhase Labs, Q4 2025: revenue $784K (-48% year over year), operating margin -730.4%, net loss $7.4M, operating cash flow −$1.2M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $784K | -11% | -48% |
| Operating profit | −$5.7M | — | — |
| Net earnings | −$7.4M | — | — |
| Operating cash flow | −$1.2M | — | — |
What changed
Revenue was $784K in Q4 2025, down 48% year over year and down 11% from the previous quarter.
Gross margin was 31.5%. Operating costs exceeded revenue by $5.7M, an operating margin of -730.4%. The quarter ended with a net loss of $7.4M, wider than the previous quarter's $6.8M loss.
Operating cash flow was −$1.2M. Non-cash charges added back $1.0M of depreciation and amortization and $433K of share-based compensation. Working capital and other items added $4.8M.
Questions
What was ProPhase Labs' revenue in the fourth quarter 2025?
ProPhase Labs (PRPH) reported revenue of $784K for the fourth quarter 2025 (Q4 2025), -48% from a year earlier and -11% from the quarter before.
Was ProPhase Labs profitable in the fourth quarter 2025?
Operating loss was $5.7M (-730.4% of revenue) and net loss $7.4M.
Source: ProPhase Labs 10-K on SEC EDGAR.